853
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Arginine deiminases: Therapeutic tools in the etiology and pathogenesis of Alzheimer's disease

Short Communication

, , , , &
Pages 121-126 | Received 20 Mar 2006, Accepted 16 Aug 2006, Published online: 04 Oct 2008

References

  • De Felice FG, Ferreira ST. β-amyloid production, aggregation and clearance as targets for therapy in Alzheimer's disease. Cell Molec Neurobiol 2002; 22: 545–563
  • Hardy J. The Alzheimer family of diseases: Many etiologies, one pathogenesis?. Proc Natl Acad Sci USA 1997; 94: 8315–8318
  • Haas J, Storch-Hagenlocher B, Biesmann A, Wildeman A. Inducible nitric oxide synthase and arginosuccinate synthetase: Co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with β-amyloid 1–42 in vitro. Neuroscience Lett 2002; 322: 121–125
  • Gelinas DS, DaSilva K, Fenill D, St. George-Hyslop P, McLaurin JA. Immunotherapy for Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 14657–14662
  • Castaño EM, Ghiso J, Prelli F, Gorevic PD, Migheli A, Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein. Biochem Biophys Res Commun 1986; 141: 782–789
  • Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC. Identification of the major A beta 1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000; 6: 143–150
  • Frederikse PH, Garland D, Zigler JS, Jr, Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 1996; 271: 10169–10174
  • Zhang L, Zhao B, Yew DT, Kusiak JW, Roth GS. Processing of Alzheimer's amyloid precursor protein during H2O2 induced apoptosis in human neuronal cells. Biochem Biophys Res Commun 1997; 235: 845–848
  • Cynober L, Le Boucher J, Vasson MP. Arginine metabolism in mammals. J Nutr Biochem 1995; 6: 402–412
  • Shen L-J, Lin W-C, Beloussow K, Hosoya K-I, Terasaki T, Ann DK, Shen W-C. Recombinant arginine deiminase as a differential modulator of inducible (eNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem Pharmacol 2003; 66: 1945–1952
  • Cooney DA, Rosenbluth RJ. Enzymes as therapeutic agents. Adv Pharmacol 1975; 12: 185–289
  • Thomas JB, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Enzymatic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumor necrosis factor α and endotoxin. Biochem J. 2002; 363: 581–587
  • Citron M. Alzheimer's disease: Treatments in discovery and development. Nature Neurosci 2002; 5(Suppl)1055–1057
  • Asaga H, Ishigami A. Protein deimination in the rat brain after kainate administration: Citrulline-containing proteins as novel marker of neuro-degeneration. Neuroscience Lett 2001; 299: 5–8
  • Lamensa JWE, Moscarello MA. Deimination of Human Myelin Basic Protein by a Peptidylarginine Deiminase from Bovine Brain. J Neurochem 1993; 61: 987–996
  • Sambandam T, Belousova M, Accaviti-Lope MA, Blanquicett C, Geurcello V, Raijmakers R, Nicholas AP. Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem Biophys Res Commun 2004; 325: 1324–1329
  • Guerrin M, Ishigami A, Mechin M-C, Nachat R, Valmary S, Sebbag M, Simon M, Senshu T, Serre G. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J 2003; 370: 167–174
  • Akiyama K, Inoue K, Senshu T. Immunocytochemical demonstration of skeletal muscle type peptidylarginine deiminase in various rat tissues. Cell Biol Int Rep 1990; 14: 267–273
  • Vincent SR, Leung E, Watanabe K. Immunohistochemical localization of peptidylarginine deiminase in rat brain. J Chem Neuronat 1992; 5: 159–168
  • Ishigami A, Oshawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N, Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 2005; 80: 120–128
  • Weickmann JL, Fahrney DE. Arginine deiminase from Mycoplasma arthritidis. J Biol Chem 1977; 252(8)2615–2620
  • Boyde TRC, Rahmatullah M. Optimisation of conditions for the colorimetric determination of citrulline using diacetyl monoxime. Anal Biochem. 1980; 107: 424–431
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of a bacteriophage. Nature 1970; 227: 680–685
  • McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, Peptidylarginine deiminase. Infect Immun 1999; 67(3248)3256
  • Monstadt GM, Holldorf AW. Arginine deiminase from Halobacterium salinarium:Purification and properties. Biochem J 1991; 273(3)739–745
  • Watanabe K, Akiyama K, Hikichi K, Ohtsuka R, Okuyama A, Senshu T. Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochim Biophys Acta 1988; 966: 375–383
  • Sugawara K, Oikawa Y, Ouchi T. Identification and properties of peptidylarginine deiminase from rabbit skeletal muscle. J Biochem 1982; 91: 1065–1071

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.